Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Corcokovic

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Oncotarget|July 10, 2018
RIOK1 kinase activity is required for cell survival irrespective of <i>MTAP</i> statusAlexandra Hörmann, Barbara Hopfgartner, Thomas Köcher, et al.
Cell Reports|April 13, 2022
Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genesAnna Köferle, Andreas Schlattl, Alexandra Hörmann, et al.
Elife|August 8, 2023
Precision RNAi using synthetic shRNAmir target sitesThomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, et al.
Nature Cancer|July 26, 2022
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signalingBirgit Wilding, Dirk Scharn, Dietrich Böse, et al.
Nature Chemical Biology|July 10, 2019
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3Jark Böttcher, David Dilworth, Ulrich Reiser, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Oncotarget|July 10, 2018
RIOK1 kinase activity is required for cell survival irrespective of <i>MTAP</i> statusAlexandra Hörmann, Barbara Hopfgartner, Thomas Köcher, et al.
Cell Reports|April 13, 2022
Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genesAnna Köferle, Andreas Schlattl, Alexandra Hörmann, et al.
Elife|August 8, 2023
Precision RNAi using synthetic shRNAmir target sitesThomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, et al.
Nature Cancer|July 26, 2022
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signalingBirgit Wilding, Dirk Scharn, Dietrich Böse, et al.
Nature Chemical Biology|July 10, 2019
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3Jark Böttcher, David Dilworth, Ulrich Reiser, et al.
Pageof 1